Makinson Cowell

Makinson Cowell is a prominent capital markets advisory firm that provides independent counsel to the boards and senior management of large-cap public companies. The firm specializes in investor relations, equity capital markets, and shareholder analysis, helping clients navigate complex interactions with the global investment community. Although they advise many leading corporations within the healthcare, biotechnology, and pharmaceutical sectors, the firm itself is a financial services entity rather than a life sciences developer. Makinson Cowell was acquired by KPMG in 2013 and subsequently by Lazard in 2020, where it now operates as a specialized unit within Lazard's capital markets advisory business.